SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PX14A6G - Notice of exempt solicitation submitted by non-management:
SEC Accession No. 0000921895-23-001127
Filing Date
2023-05-11
Accepted
2023-05-11 11:34:03
Documents
1
Effectiveness Date
2023-05-11

Document Format Files

Seq Description Document Type Size
1 px14a6g13781002_05112023.htm PX14A6G 11317
  Complete submission text file 0000921895-23-001127.txt   12829
Mailing Address #140, 14315 - 118 AVENUE EDMONTON A0 T5L 4S6
Business Address #140, 14315 - 118 AVENUE EDMONTON A0 T5L 4S6 250-744-2487
Aurinia Pharmaceuticals Inc. (Subject) CIK: 0001600620 (see all company filings)

IRS No.: 981231763 | Fiscal Year End: 1231
Type: PX14A6G | Act: 34 | File No.: 001-36421 | Film No.: 23909767
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O OGIER FIDUCIARY SERVICE (CAYMAN) LTD 89 NEXUS WAY, GERMANA BAY GRAND CAYMAN E9 KY1-9007
Business Address C/O OGIER FIDUCIARY SERVICE (CAYMAN) LTD 89 NEXUS WAY, GERMANA BAY GRAND CAYMAN E9 KY1-9007 41 79200 4774
MKT Capital Ltd. (Filed by) CIK: 0001975258 (see all company filings)

IRS No.: 000000000
Type: PX14A6G